GCP
BSX icon

Gill Capital Partners’s Boston Scientific BSX Stock Holding History

Gill Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Hold
515
– – 0.01% 367
2026
Q1 		$32.3K Buy
+515
New +$41.2K 0.01% 308

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Gill Capital Partners's BSX Position: Q2 2026 in Review

Gill Capital Partners held its Boston Scientific (BSX) position steady in Q2 2026 at 515 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #367.

Gill Capital Partners first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $32.3K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Gill Capital Partners held 515 shares of Boston Scientific worth $22K as of Q2 2026.
  • Gill Capital Partners left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of Gill Capital Partners's portfolio in Q2 2026, its #367 holding.
  • Gill Capital Partners first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Gill Capital Partners's Boston Scientific position peaked at $32.3K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.